Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 6,201–6,225 of 27,380 studies, newest first · page 249 of 1096.

September 2024 25

  1. 2024-09-17

    Plasma markers of neurodegeneration, latent cognitive abilities and physical activity in healthy aging

    ✓ Peer-reviewed Biomarkers Scientific reports

    Key finding: The results showed that NfL was negatively associated with working memory, and that NfL interacted with moderate-to-vigorous physical activity in its association with episodic memory. +1 more finding

  2. 2024-09-17
  3. 2024-09-16

    Paying for advance care planning in medicare: Impacts on care and spending near end of life

    ✓ Peer-reviewed Health systems and care delivery Journal of health economics

    Key finding: Among decedents, death is significantly less likely to occur in the hospital, and total and inpatient spending within the last 30 days of life fall significantly. +1 more finding

  4. 2024-09-16

    AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling

    ✓ Peer-reviewed Digital health tools Ageing research reviews

    Key finding: Alzheimer's disease (AD) presents a significant challenge in neurodegenerative research and clinical practice due to its complex etiology and progressive nature.

  5. 2024-09-15

    PM2.5 is linked to Alzheimer's syndrome and delirium: a mendelian randomization analysis

    ✓ Peer-reviewed Risk factors International journal of clinical and experimental pathology

    Key finding: The odds ratio (OR) for Alzheimer's disease was 0.996 with a p-value of 0.443 using the inverse variance weighted algorithm, and the OR associated with the outcome variable of delirium was 0.393 with a p-value of 0.343. +2 more findings

  6. 2024-09-14

    Resting-state functional connectivity abnormalities in subjective cognitive decline: A 7T MRI study

    ✓ Peer-reviewed Brain scans and imaging Neurobiology of aging

    Key finding: Compared to the other two groups, SCD showed higher FC in frontal default mode network (DMN) and insular and superior temporal nodes of ventral attention network (VAN). +1 more finding

  7. 2024-09-14

    Epigenetic age acceleration and cognitive performance over time in older adults

    ✓ Peer-reviewed Genetics Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Associations between epigenetic AA and cognitive performance over-time varied by sex. +4 more findings

  8. 2024-09-14

    The influences of ApoE isoforms on endothelial adherens junctions and actin cytoskeleton responding to mCRP

    ✓ Peer-reviewed Genetics Angiogenesis

    Key finding: Using phosphor-proteomic profiling, we found altered cytoskeleton proteins in the microvasculature of AD brains, including increased levels of hyperphosphorylated tau (pTau) and the actin-related protein, LIMA1. +2 more findings

  9. 2024-09-14

    Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease

    ✓ Peer-reviewed Laboratory science Nature Communications

    Key finding: The AD+LB+ group showed worst baseline performance for most cognitive outcomes and compared to the AD+LB- group faster global cognitive decline and more cortical hypometabolism, particularly in posterior brain regions. +1 more finding

  10. 2024-09-13

    Production of Terpene Trilactones from Cell and Organ Cultures of Ginkgo biloba

    ✓ Peer-reviewed Risk factors Plants

    Key finding: In addition, the accumulation of TTLs in these plants is affected by age, sex, and seasonal and geographical variations. +4 more findings

  11. 2024-09-13

    Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease

    ✓ Peer-reviewed Tau biomarkers Neurology

    Key finding: It remains unknown whether the associations between protective lifestyles and sporadic dementia risk reported in observational studies also affect age at symptom onset (AAO) in autosomal dominant Alzheimer disease (ADAD) with predominant genetic influences. +3 more findings

  12. 2024-09-13

    Core CSF Biomarker Profile in Cerebral Amyloid Angiopathy: Updated Meta-Analysis

    ✓ Peer-reviewed Tau biomarkers Neurology

    Key finding: There is a clear need to characterize and validate molecular biomarkers of cerebral amyloid angiopathy (CAA), in an effort to improve diagnostics, especially in the context of patients with Alzheimer disease (AD) receiving immunotherapies (for whom underlying CAA is the driver of amyloid-related imaging abnormalities). +3 more findings

  13. 2024-09-12

    Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies

    ✓ Peer-reviewed Brain scans and imaging Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Elevated CSF p-tau181 and cortical 18F-PI-2620 binding was characteristic for AD while normal CSF p-tau181 with elevated subcortical 18F-PI-2620 binding was characteristic for 4RTs. 18F-PI-2620-assessed posterior cortical hypoperfusion could be used as an additional neuronal injury biomarker in AD. +4 more findings

  14. 2024-09-12

    Association of white matter hyperintensities with cognitive decline and neurodegeneration

    ✓ Peer-reviewed Tau biomarkers Frontiers in aging neuroscience

    Key finding: Higher WMH volume was associated with older age, lower CSF amyloid-β levels, hypertension, and smoking history (all p ≤ 0.001), as well as cognitive status (MCI, p < 0.001; dementia, p = 0.008), but not with CSF tau levels. +4 more findings

  15. 2024-09-11

    Amyloid-β Causes NMDA Receptor Dysfunction and Dendritic Spine Loss through mGluR1 and AKAP150-Anchored Calcineurin Signaling

    ✓ Peer-reviewed Disease mechanisms The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: By employing AKAP150 knock-in mice of both sexes with a mutation that disrupts CaN anchoring to AKAP150, we revealed that local, postsynaptic AKAP-CaN-LTD signaling was required for Aβ-mediated impairment of NMDAR synaptic Ca2+ influx, inhibition of LTP, and dendritic spine loss. +2 more findings

  16. 2024-09-11

    Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivo

    ✓ Peer-reviewed Brain tissue and pathology Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Across cohorts, the main biomarker associated with α-synuclein positivity at baseline was higher levels of Aβ pathology (all p values ≤ 0.02), but not tau. +4 more findings

  17. 2024-09-11

    Predicting CDR status over 36 months with a recall-based digital cognitive biomarker

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The best predictor of CDR at 36 months was M, a DCB reflecting recall ability (area under the curve = 0.84), outperforming traditional scores. +4 more findings

  18. 2024-09-11
  19. 2024-09-11

    Can cerebrospinal fluid biomarkers tell us something about financial capacity in Alzheimer's disease patients? A preliminary study

    ✓ Peer-reviewed Tau biomarkers Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater

    Key finding: Although diagnostic markers in cerebrospinal fluid (CSF) have become a rapidly growing research field, they have not as yet been investigated in relation to capacities that are of interest to geriatric psychiatry and neuropsychology, such as financial capacity. +3 more findings

  20. 2024-09-10

    Factors associated with cognitive reserve according to education level

    ✓ Peer-reviewed Risk factors Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: In the low-education group, low literacy, long sleep duration(>8 h/day), and diabetes were negatively associated with CR, whereas cognitive and physical activity were positively associated with CR. +4 more findings

  21. 2024-09-09
  22. 2024-09-07

    Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Alzheimer's research & therapy

    Key finding: We found a significant reduction in PSD-95-actin association in synaptosomes from middle-aged APP/PS1 mice compared to wild-type (WT) mice. +4 more findings

  23. 2024-09-06

    Multi-omics analysis of gut-brain axis reveals novel microbial and neurotransmitter signatures in patients with arteriosclerotic cerebral small vessel disease

    ✓ Peer-reviewed Disease mechanisms Pharmacological research

    Key finding: Although its underlying pathogenesis remains poorly understood, both inflammaging and gut microbiota dysbiosis have been hypothesized to play significant roles. +4 more findings

  24. 2024-09-06

    A Systematic Review of Antidepressants and Psychotherapy Commonly Used in the Treatment of Late Life Depression for Their Effects on Cognition

    ✓ Peer-reviewed Risk factors The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: Sertraline and vortioxetine had significant positive effects on processing speed and memory. +2 more findings

  25. 2024-09-06

    Cognitive modeling of the Mnemonic Similarity Task as a digital biomarker for Alzheimer's disease

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: A MPT model of the MST can detect individuals with AD prior to cognitive decline, making it a potentially useful tool for screening and monitoring older adults during the asymptomatic phase of AD.

Browse the library by subject, with the full score breakdown →